VRML Related Corporate News

Nov 28, 2012 10:44 AM Vermillion (VRML) Reports Publication of Positive Top-Line Results for OVA1

Jul 30, 2012 08:32 AM Vermillion (VRML) Reports Encouraging Top-Line Data from OVA500

May 8, 2012 11:53 AM Vermillion (VRML) Shares on the Move as Co. Gets Patent for Platelet Biomarkers for Cancer

Apr 16, 2012 08:33 AM Vermillion (VRML) Gets Patent for Ovarian Cancer Biomarkers

Mar 28, 2012 08:32 AM Vermillion (VRML) Gets New Biomarket Patent for Ovarian Cancer

Mar 6, 2012 09:44 AM Vermillion (VRML) Surges As OVA1 Test Gets Approval

Jan 4, 2012 08:10 AM Vermillion (VRML) to Streamline Ops, Will Reduce Overall Headcount

Oct 3, 2011 08:32 AM Vermillion (VRML) Reports Strong Top-Line Results for VASCLIR

Aug 1, 2011 08:33 AM Vermillion (VRML) Receives Notice of Allowance from USPTO for Peripheral Artery Disease Patent

May 24, 2011 09:22 AM Vermillion (VRML), Quest (DGX) Report Publication of Strong OVA1 Data in IDing Ovarian Cancer Masses

May 12, 2011 02:10 PM Vermillion (VRML) Shares Surge 36% Amid Positive OVA1 Blood Test Data

Apr 4, 2011 08:37 AM Vermillion (VRML) Signs Agreement to Bring OVA1 to India

Mar 8, 2011 08:49 AM Vermillion (VRML) Presents Positive CA125 Data

Jan 11, 2011 05:45 PM Vermillion (VRML) Issued U.S. Patent Covering Peripheral Artery Disease

Sep 20, 2010 08:18 AM Vermillion (VRML) Announces OVA1 Receives a CE Mark

Jul 6, 2010 08:04 AM Vermillion (VRML) to Relist on Nasdaq Stock Market